News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Luisa Soares Miranda: Excited to Share our Latest Publication on Trastuzumab Deruxtecan in Previously Treated HER2-Low MBC
Luisa Soares Miranda/LinkedIn
Jul 10, 2025, 15:12

Luisa Soares Miranda: Excited to Share our Latest Publication on Trastuzumab Deruxtecan in Previously Treated HER2-Low MBC

Luisa Soares Miranda, Medical Oncology Resident at Santo António University Hospital Center, shared a post on LinkedIn:

“Excited to share our latest publication:

‘Trastuzumab Deruxtecan in Previously Treated HER2-Low Metastatic Breast Cancer: Real-World Multicentric Study in the Portuguese Population’

This work was only possible thanks to the outstanding teamwork. Truly grateful to everyone involved!”

Title: Trastuzumab Deruxtecan in Previously Treated HER2-Low Metastatic Breast Cancer: Real-World Multicentric Study in the Portuguese Population

Authors: Luísa Soares Miranda, Maria João Sousa, Miguel Martins Braga, Marisa Couto, Isabel Vieira Fernandes, Francisca Abreu, Inês Eiriz, Catarina Lopes Fernandes, Alice Fonseca Marques, Maria Teresa Marques, Raquel Romão, Fernando Gonçalves, Joana Simões, António Araújo

Read the Full Article on Cancers Journal

Luisa Soares Miranda: Excited to Share our Latest Publication on Trastuzumab Deruxtecan in Previously Treated HER2-Low MBC

More posts featuring Trastuzumab Deruxtecan.

Alice Fonseca Marques Antonio Araujo Breast Cancer cancer Catarina Lopes Fernandes Fernando Gonçalves Francisca Abreu Inês Eiriz Isabel Vieira Fernandes Joana Simões Luisa Soares Miranda Maria João Sousa Maria Teresa Marques Marisa Couto Miguel Martins Braga OncoDaily Oncology Raquel Romão Trastuzumab deruxtecan
Special Coverage
Science
Jul 10, 2025, 15:12
Luisa Soares Miranda: Excited to Share our Latest Publication on Trastuzumab Deruxtecan in Previously Treated HER2-Low MBC
Blog
Jul 10, 2025, 15:11
Francisco J Esteva: Post-Chemo Weight Gain - Fight Back For Your Health and Confidence
Blog
Jul 10, 2025, 15:01
DPD Deficiency and Why It’s Important in Colorectal Cancer Treatment - Global Colon Cancer Association
Blog
Jul 10, 2025, 14:59
Bo Wang: How Recent Advances in Foundation Models Are Redefining What’s Possible in Cancer Diagnostics
Blog
Jul 10, 2025, 14:51
Screening Recommendations For Common Cancers - Asian Fund for Cancer Research
Societies
Jul 10, 2025, 14:47
Registration is Open for the ESMO Asia Congress 2025
Blog
Jul 10, 2025, 14:45
Leukemia and Breast Cancer Patient Leveraged Her Social Media Savvy to Navigate the Most Difficult Journey of Her Life - City of Hope
Blog
Jul 10, 2025, 14:36
Mladen Marinkovic: 'Clinical Oncology with Radiotherapy' is Offering a Comprehensive and Practical Overview of Oncology
Blog
Jul 10, 2025, 14:35
Agenus Thanks ESMO and Ben Schlechter for Sharing the New Data of BOT/BAL in Refractory MSS CRC
Science
Jul 10, 2025, 14:26
Myeloma Paper of the Day, July 10th, Suggested by Robert Orlowski
Blog
Jul 10, 2025, 14:16
Voice of the Families, Post 36 Ninsimma and Her Mother - CANCaRe Africa
Career
Jul 10, 2025, 14:15
Leadership Transition: Brad Cairns to Lead Huntsman Cancer Institute After Mary Beckerle’s Tenure